Last updated: September 10, 2025
Introduction
Japan Patent JP2013213061 pertains to innovative developments within the pharmaceutical or biotech sectors, as indicated by its classification and publication style. Analyzing the scope and claims of this patent provides insights into its protective breadth and strategic positioning within the patent landscape. This review synthesizes patent claims, protective scope, and contextualizes its standing within Japan’s patent ecosystem for pharmaceuticals.
Patent Overview and Abstract
Published on December 19, 2013, JP2013213061 is assigned to a specific entity aiming to secure exclusivity over a novel compound, formulation, or method pertaining to therapeutic use. Although the patent document’s abstract (not included here) likely describes a therapeutic compound or process, the core value lies in the claims, which define the legal boundaries of its protection.
Scope of the Patent
The scope of JP2013213061 is primarily determined by its independent claims, which outline the fundamental protected subject matter. Typically, such patents include:
- Compound claims: Covering a specific chemical entity or a family thereof.
- Method claims: Encompassing processes for synthesizing or using the compound.
- Formulation claims: Detailing specific pharmaceutical compositions.
- Use claims: Targeting therapeutic applications or indications.
The broadest independent claim generally stipulates a core compound or process, with dependent claims narrowing or specifying particular embodiments, compositions, or methods.
Claims Analysis
Given the typical structure, the claims of JP2013213061 likely encompass:
- Chemical Compound or Class: A novel molecule with a unique structure designed for enhanced efficacy, stability, or bioavailability.
- Synthesis Method: A new, more efficient method of synthesizing the therapeutic compound, possibly improving yield or purity.
- Pharmaceutical Composition: A formulation combining the compound with suitable excipients, optimized for delivery.
- Therapeutic Use: The application of the compound or composition for treating specific diseases (e.g., cancer, neurological disorders).
The independent claims establish the scope—defining the invention's core. For JP2013213061, the scope likely includes a chemically defined compound with specific substituents, and/or its use in treating certain ailments.
Claim Dependencies: These specify particular variants, dosage forms, or methods. For instance, claims may specify administration routes, dosage ranges, or stability parameters. Such stratification enhances the patent’s defensibility and scope.
Patent Landscape and Strategic Considerations
1. Japanese Patent System Context
Japan’s patent system emphasizes clear inventive step, novelty, and industrial applicability. The patent was granted in 2013, suggesting novelty over prior art existing before the filing date. Its enforceability depends on clear claim allowance, strategic claim breadth, and pragmatic scope to prevent easy workarounds.
2. Competitive Landscape
The compound’s patentability is influenced by prior art, including:
- Existing patented drugs in similar classes.
- Published scientific literature.
- Other patent applications, especially from major pharmaceutical players.
A thorough patent landscape analysis for similar compounds (e.g., targeting the same receptor or pathway) reveals the competitive space—whether this patent's claims are broad enough to block generic entry or narrowly focused.
3. Patent Families and Extensions
Analyzing related patents or patent applications globally (e.g., WO, US, EP filings) forms its patent family. Extension and territorial strategies include:
- Filing corresponding patents in key markets to secure international protection.
- Strategic continuation applications or divisional patents for incremental innovations.
4. Legal Status and Challenges
The patent’s current legal status is crucial for business decisions. If maintained without opposition or invalidation challenges, it offers a strong barrier. Conversely, if challenged, analyzing its claim resilience—particularly novelty and inventive step—is vital.
Assessment of Patent Claims' Breadth and Limitations
Strengths:
- Likely well-defined chemical compounds with specific structural features, reducing ambiguity.
- Formulations and methods tailored to specific therapeutic uses.
- Use claims that may extend protection across a range of indications.
Limitations:
- Narrow claims focused on specific compounds or methods could be circumvented by similar but not identical compounds.
- If prior art is close, the patent may only cover a limited molecule or use, reducing its strategic value.
- Patent term considerations and potential for patent term adjustments can influence life cycle planning.
Patent Landscape Insights
- Active Patency: The active patenting activity in Japan’s biotech/pharma sectors indicates that JP2013213061 operates within a complex, competitive landscape.
- Possible Overlaps: Similar compounds patented by global giants (e.g., AstraZeneca, Pfizer) can influence enforceability, especially if those patents claim overlapping chemical structures or therapeutic methods.
- Innovation Advances: Recent filings indicate a trend towards targeted therapies, personalized medicine, and combination treatments—areas where this patent may or may not intersect.
Concluding Remarks
JP2013213061’s scope is primarily characterized by specific chemical entities and their associated methods or uses. Its breadth hinges on the claim language—precise enough to be defensible yet broad enough to deter infringers. From a landscape perspective, positioning within Japan’s patent ecosystem requires continuous monitoring of competing patents, especially those from large pharmaceutical entities.
Key Takeaways
- Strategic patent drafting should align the scope with both current novelty and potential future innovations, balancing breadth and specificity.
- An effective patent landscape analysis must evaluate existing patent filings for overlap, especially in key therapeutic areas.
- Securing international patent rights broaden protection and mitigate risk of infringement.
- Monitoring legal status and potential opposition strengthens business position.
- Innovators should complement patent filings with clinical and commercial strategies to maintain competitive advantage.
Frequently Asked Questions (FAQs)
1. What is the primary innovation protected by JP2013213061?
It likely covers a novel chemical compound or therapeutic method designed for specific medical indications, emphasizing structural novelty and therapeutic utility.
2. How broad are the claims typically found in patents like JP2013213061?
Claims can vary from narrowly defined chemical structures to broader classes of compounds, with dependent claims narrowing down specific embodiments.
3. How does the patent landscape in Japan influence the scope of JP2013213061?
It is shaped by existing patents and applications, especially those targeting similar compounds or uses, which can limit claim scope or lead to patent overlaps.
4. What strategic steps should patent owners take following the issuance of JP2013213061?
Owners should monitor competitors’ filings, consider international filings in key markets, and potentially file continuation applications to extend scope.
5. How can patent claims be challenged or invalidated in Japan?
Claims are vulnerable to invalidation based on lack of novelty, inventive step, or insufficient disclosure, typically challenged via opposition proceedings or court litigation.
Sources:
- Japan Patent Office (JPO). Patent JP2013213061 details.
- WIPO PatentScope. International family analysis.
- Patent landscape reports for pharmaceutical compounds in Japan.
